Sfoglia per Rivista HEMASPHERE
The EHA research roadmap: malignant myeloid diseases
2021-01-01 Dohner, H.; Malcovati, L.; Ossenkoppele, G. J.; Hochhaus, A.; Maria Vannucchi, A.; Bullinger, L.; Cervantes, F.; Craddock, C.; De Witte, T.; Dohner, K.; Dombret, H.; Fenaux, P.; Geissler, J.; Germing, U.; Guilhot, F.; Harrison, C.; Hellstrom-Lindberg, E.; Passamonti, F.; Sierra, J.; Skoda, R.; Wierzbowska, A.
EPICOVIDEHA: A ready to use platform for epidemiological studies in hematological patients with COVID-19
2021-01-01 Salmanton-Garcia, J.; Busca, A.; Cornely, O. A.; Corradini, P.; Hoenigl, M.; Klimko, N.; Marchesi, F.; Pagliuca, A.; Passamonti, F.; Koehler, P.; Pagano, L.
Fedratinib improves myelofibrosis-related symptoms and health-related quality of life in patients with myelofibrosis previously treated with ruxolitinib: patient-reported outcomes from the phase II JAKARTA2 trial
2021-01-01 Harrison, C. N.; Schaap, N.; Vannucchi, A. M.; Kiladjian, J. -J.; Jourdan, E.; Silver, R. T.; Schouten, H. C.; Passamonti, F.; Zweegman, S.; Talpaz, M.; Verstovsek, S.; Tang, D.; Abraham, P.; Lord-Bessen, J.; Rose, S.; Guo, S.; Liao, W.; Mesa, R. A.
Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia
2020-01-01 Fontana, D.; Ramazzotti, D.; Aroldi, A.; Redaelli, S.; Magistroni, V.; Pirola, A.; Niro, A.; Massimino, L.; Mastini, C.; Brambilla, V.; Bombelli, S.; Bungaro, S.; Morotti, A.; Rea, D.; Stagno, F.; Martino, B.; Campiotti, L.; Caocci, G.; Usala, E.; Merli, M.; Onida, F.; Bregni, M.; Elli, E. M.; Fumagalli, M.; Ciceri, F.; Perego, R. A.; Pagni, F.; Mologni, L.; Piazza, R.; Gambacorti-Passerini, C.
Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial
2021-01-01 Mesa, R. A.; Schaap, N.; Vannucchi, A. M.; Kiladjian, J. -J.; Passamonti, F.; Zweegman, S.; Talpaz, M.; Verstovsek, S.; Rose, S.; Abraham, P.; Lord-Bessen, J.; Tang, D.; Guo, S.; Ye, X.; Harrison, C. N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The EHA research roadmap: malignant myeloid diseases | 1-gen-2021 | Dohner, H.; Malcovati, L.; Ossenkoppele, G. J.; Hochhaus, A.; Maria Vannucchi, A.; Bullinger, L.; Cervantes, F.; Craddock, C.; De Witte, T.; Dohner, K.; Dombret, H.; Fenaux, P.; Geissler, J.; Germing, U.; Guilhot, F.; Harrison, C.; Hellstrom-Lindberg, E.; Passamonti, F.; Sierra, J.; Skoda, R.; Wierzbowska, A. | |
| EPICOVIDEHA: A ready to use platform for epidemiological studies in hematological patients with COVID-19 | 1-gen-2021 | Salmanton-Garcia, J.; Busca, A.; Cornely, O. A.; Corradini, P.; Hoenigl, M.; Klimko, N.; Marchesi, F.; Pagliuca, A.; Passamonti, F.; Koehler, P.; Pagano, L. | |
| Fedratinib improves myelofibrosis-related symptoms and health-related quality of life in patients with myelofibrosis previously treated with ruxolitinib: patient-reported outcomes from the phase II JAKARTA2 trial | 1-gen-2021 | Harrison, C. N.; Schaap, N.; Vannucchi, A. M.; Kiladjian, J. -J.; Jourdan, E.; Silver, R. T.; Schouten, H. C.; Passamonti, F.; Zweegman, S.; Talpaz, M.; Verstovsek, S.; Tang, D.; Abraham, P.; Lord-Bessen, J.; Rose, S.; Guo, S.; Liao, W.; Mesa, R. A. | |
| Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia | 1-gen-2020 | Fontana, D.; Ramazzotti, D.; Aroldi, A.; Redaelli, S.; Magistroni, V.; Pirola, A.; Niro, A.; Massimino, L.; Mastini, C.; Brambilla, V.; Bombelli, S.; Bungaro, S.; Morotti, A.; Rea, D.; Stagno, F.; Martino, B.; Campiotti, L.; Caocci, G.; Usala, E.; Merli, M.; Onida, F.; Bregni, M.; Elli, E. M.; Fumagalli, M.; Ciceri, F.; Perego, R. A.; Pagni, F.; Mologni, L.; Piazza, R.; Gambacorti-Passerini, C. | |
| Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial | 1-gen-2021 | Mesa, R. A.; Schaap, N.; Vannucchi, A. M.; Kiladjian, J. -J.; Passamonti, F.; Zweegman, S.; Talpaz, M.; Verstovsek, S.; Rose, S.; Abraham, P.; Lord-Bessen, J.; Tang, D.; Guo, S.; Ye, X.; Harrison, C. N. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile